As part of Operation Warp Speed, which is a public-private partnership between the Trump administration and other companies to create and increase the development, manufacturing, and distribution of a covid-19 vaccine, the Trump administration announced on Friday that they have partnered with CVS and Walgreens. This partnership will serve to provide free vaccines to those living in nursing homes and the staff in those facilities. These facilities include long-term care, skilled nursing facilities, nursing homes, assisted living facilities, residential care homes and adult family homes.
This will be implemented once a vaccine has been created and is certifiably safe and effective. John Standley is the president of Walgreens and he mentioned how important this partnership is to saving lives. He continued, “Ensuring access to COVID-19 vaccines, particularly among our most vulnerable populations, will be critical to saving lives and helping our nation recover from the pandemic.”
Health and Human Services Secretary Alex Azar tweeted:
The deputy director of the CDC, Jay Butler, said that there are about 15,000 long-term care facilities and 35,000 assisted living facilities in America. Facilities can choose to opt-in to the program and if they don’t, they may be able to receive vaccines from local pharmacies or other sources.
CVS and Walgreens will coordinate with facilities and schedule on-site clinic days; it’s anticipated there will be 3 total visits over a two month period to administer both doses of the vaccines to residents and the staff.
In an official statement Alex Azar said, “Protecting the vulnerable has been the number one priority of the Trump Administration’s response to COVID-19, and that commitment will continue through distributing a safe and effective vaccine earliest to those who need it most.
Several companies are developing vaccines, some of the leading companies are Johnson & Johnson and AstraZeneca. Johnson & Johnson recently announced that they had to pause their study because a patient began experiencing adverse effects. Representatives for the company said that with any study that can be expected and production should resume as quickly as possible. They also said the patient experiencing adverse effects is being treated and the case is being reviewed.